130 related articles for article (PubMed ID: 23470457)
1. Akt destabilizes p57 (Kip2) : Akt at the converging crossroad?
Lo HW
Cell Cycle; 2013 Mar; 12(6):870-1. PubMed ID: 23470457
[No Abstract] [Full Text] [Related]
2. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.
Zhao R; Yang HY; Shin J; Phan L; Fang L; Che TF; Su CH; Yeung SC; Lee MH
Cell Cycle; 2013 Mar; 12(6):935-43. PubMed ID: 23421998
[TBL] [Abstract][Full Text] [Related]
3. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
4. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
5. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.
Chen B; Zhao R; Su CH; Linan M; Tseng C; Phan L; Fang L; Yang HY; Yang H; Wang W; Xu X; Jiang N; Cai S; Jin F; Yeung SC; Lee MH
Cell Cycle; 2012 Dec; 11(24):4633-41. PubMed ID: 23187808
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of p57 KIP2 expression in breast cancer.
Xu XY; Wang WQ; Zhang L; Li YM; Tang M; Jiang N; Cai SL; Wei L; Jin F; Chen B
Asian Pac J Cancer Prev; 2012; 13(10):5033-6. PubMed ID: 23244105
[TBL] [Abstract][Full Text] [Related]
7. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
[TBL] [Abstract][Full Text] [Related]
8. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
9. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
Bilodeau S; Roussel-Gervais A; Drouin J
Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
[TBL] [Abstract][Full Text] [Related]
10. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
Lu Z; Hunter T
Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.
Zhou BP; Liao Y; Xia W; Spohn B; Lee MH; Hung MC
Nat Cell Biol; 2001 Mar; 3(3):245-52. PubMed ID: 11231573
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells.
Marches R; Uhr JW
Int J Cancer; 2004 Nov; 112(3):492-501. PubMed ID: 15382077
[TBL] [Abstract][Full Text] [Related]
14. p57KIP2: "Kip"ing the cell under control.
Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
[TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
16. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
17. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53.
Xue Y; Chen J; Choi HH; Phan L; Chou PC; Zhao R; Yang H; Santiago J; Liu M; Yeung GE; Yeung SC; Lee MH
Cell Cycle; 2012 Nov; 11(22):4181-90. PubMed ID: 23095642
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
19. Loss of p27
Kim GJ; Kim DH; Min KW; Kim YH; Oh YH
Pathol Res Pract; 2018 Apr; 214(4):565-571. PubMed ID: 29482985
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor 2 fluorescence in situ hybridization and P57KIP2 immunohistochemistry using tissue microarray: Improving histopathological subtyping of hydatidiform mole.
López CL; Figueira Gouvêa AL; Rodrigues FR; Braga A; Valente Machado MD; Lopes VS
Placenta; 2020 Sep; 99():166-172. PubMed ID: 32810764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
